BACKGROUND: Patients with Medicaid are much less likely to undergo bariatric surgery compared to those with commercial insurance. The aims of this study were to compare outcomes after laparoscopic Roux-en-Y gastric bypass (LRYGB) for patients covered by Medicaid, other (non-Medicaid) government insurance, and commercial insurance. METHODS: This was a retrospective cohort study of all eligible patients who underwent LRYGB between July 2004 and October 2011 at a single university hospital (n = 450). Multivariable regression analysis was used to compare percent weight loss (PWL), absolute weight loss (AWL), hospital length of stay (LOS) ≥3 days, and 30-day readmission rates. Analyses were adjusted for appropriate covariates. RESULTS: There was a nonsignificant increase in PWL in Medicaid patients at 2 months (p = 0.08), 6 months (p = 0.09), and 12 months (p = 0.17) compared to commercial insurance patients. Similarly, there was a nonsignificant increase in AWL in Medicaid patients at 2 months (p = 0.054), 6 months (p = 0.08), and 12 months (p = 0.14) compared to commercial insurance patients. Medicaid patients had similar PWL and AWL compared to those with other government insurance (p ≥ 0.29 at all time points). Medicaid patients were more likely to have a hospital LOS ≥ 3 days (OR 2.03; 95 % confidence interval (CI) 1.09-3.77) and a hospital readmission within 30 days of discharge (odds ratio (OR) 2.84; 95 % CI 1.15-6.96) compared to commercial insurance patients. CONCLUSIONS: These data should be considered as states expand Medicaid and make decisions regarding treatment of severe obesity. Interventions to decrease hospital LOS and the 30-day readmission rate, particularly in Medicaid patients, should be explored.
BACKGROUND:Patients with Medicaid are much less likely to undergo bariatric surgery compared to those with commercial insurance. The aims of this study were to compare outcomes after laparoscopic Roux-en-Y gastric bypass (LRYGB) for patients covered by Medicaid, other (non-Medicaid) government insurance, and commercial insurance. METHODS: This was a retrospective cohort study of all eligible patients who underwent LRYGB between July 2004 and October 2011 at a single university hospital (n = 450). Multivariable regression analysis was used to compare percent weight loss (PWL), absolute weight loss (AWL), hospital length of stay (LOS) ≥3 days, and 30-day readmission rates. Analyses were adjusted for appropriate covariates. RESULTS: There was a nonsignificant increase in PWL in Medicaid patients at 2 months (p = 0.08), 6 months (p = 0.09), and 12 months (p = 0.17) compared to commercial insurance patients. Similarly, there was a nonsignificant increase in AWL in Medicaid patients at 2 months (p = 0.054), 6 months (p = 0.08), and 12 months (p = 0.14) compared to commercial insurance patients. Medicaid patients had similar PWL and AWL compared to those with other government insurance (p ≥ 0.29 at all time points). Medicaid patients were more likely to have a hospital LOS ≥ 3 days (OR 2.03; 95 % confidence interval (CI) 1.09-3.77) and a hospital readmission within 30 days of discharge (odds ratio (OR) 2.84; 95 % CI 1.15-6.96) compared to commercial insurance patients. CONCLUSIONS: These data should be considered as states expand Medicaid and make decisions regarding treatment of severe obesity. Interventions to decrease hospital LOS and the 30-day readmission rate, particularly in Medicaid patients, should be explored.
Authors: Eric A Finkelstein; Olga A Khavjou; Hope Thompson; Justin G Trogdon; Liping Pan; Bettylou Sherry; William Dietz Journal: Am J Prev Med Date: 2012-06 Impact factor: 5.043
Authors: Brian Hong; Edwin Stanley; Susan Reinhardt; Kristen Panther; Michael J Garren; Jon C Gould Journal: Surg Obes Relat Dis Date: 2011-06-15 Impact factor: 4.734
Authors: Ehab Akkary; Abby Nerlinger; Sunkyung Yu; James Dziura; Andrew J Duffy; Robert L Bell Journal: Surg Endosc Date: 2008-09-24 Impact factor: 4.584
Authors: Genevieve B Melton; Kimberley E Steele; Michael A Schweitzer; Anne O Lidor; Thomas H Magnuson Journal: J Gastrointest Surg Date: 2007-12-11 Impact factor: 3.452
Authors: Aristithes G Doumouras; Fady Saleh; Sama Anvari; Scott Gmora; Mehran Anvari; Dennis Hong Journal: Surg Endosc Date: 2017-04-13 Impact factor: 4.584
Authors: Benjamin Clapp; Andres Vivar; Christian Castro; Jisoo Kim; Jesus Gamez; Christopher Dodoo; Brian Davis Journal: JSLS Date: 2022 Apr-Jun Impact factor: 1.789
Authors: Erin Takemoto; Bruce M Wolfe; Corey L Nagel; Walter Pories; David R Flum; Alfons Pomp; James Mitchell; Janne Boone-Heinonen Journal: Int J Obes (Lond) Date: 2018-06-11 Impact factor: 5.095
Authors: Ellie Y Chen; Benjamin T Fox; Andrew Suzo; Jacob A Greenberg; Guilherme M Campos; Michael J Garren; Luke M Funk Journal: Surg Laparosc Endosc Percutan Tech Date: 2016-02 Impact factor: 1.719
Authors: Natalie Liu; Manasa Venkatesh; Bret M Hanlon; Anna Muraveva; Morgan K Johnson; Lawrence P Hanrahan; Luke M Funk Journal: Ann Surg Open Date: 2021-01-07
Authors: Piotr Major; Michał Wysocki; Grzegorz Torbicz; Natalia Gajewska; Alicja Dudek; Piotr Małczak; Michał Pędziwiatr; Magdalena Pisarska; Dorota Radkowiak; Andrzej Budzyński Journal: Obes Surg Date: 2018-02 Impact factor: 4.129